GeneDx to Participate in Upcoming Investor Conferences

Rhea-AI Summary

GeneDx (Nasdaq: WGS) announced its participation in two upcoming investor conferences in June 2024. The company will present at the Jefferies Healthcare Conference in New York City on June 5 at 9:00 a.m. ET and at the 44th Annual Goldman Sachs Global Healthcare Conference in Miami, Florida on June 10 at 3:20 p.m. ET. Live and archived webcasts of the presentations will be accessible on the GeneDx investor relations website. GeneDx focuses on delivering improved health outcomes through genomic insights and offers exome and genome tests to provide personalized health plans, accelerate drug discovery, and enhance health system efficiencies.

Positive

• GeneDx is participating in high-profile investor conferences, which may increase visibility and investor interest.
• Live and archived webcasts of the presentations provide broader access and transparency to shareholders.
• GeneDx's focus on genomic insights and personalized health plans aligns with current trends in precision medicine.

Negative

• No new financial or clinical data is presented in the PR, leaving investors without updated metrics to evaluate performance.
• Participation in conferences does not guarantee positive outcomes or stock performance improvement.
• The PR does not address any challenges or risks that GeneDx might be facing, leaving potential uncertainties unaddressed.

STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June:

• Jefferies Healthcare Conference - New York City, New York
  Fireside chat on Wednesday, June 5 at 9:00 a.m. ET
• 44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida
  Fireside chat on Monday, June 10 at 3:20 p.m. ET

Live and archived webcasts of the presentation will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.

Investor Relations Contact:
investors@GeneDx.com

Media Contact:
press@GeneDx.com

 

FAQ

What investor conferences will GeneDx participate in June 2024?

GeneDx will participate in the Jefferies Healthcare Conference on June 5 and the 44th Annual Goldman Sachs Global Healthcare Conference on June 10.

When is GeneDx's presentation at the Jefferies Healthcare Conference?

GeneDx will present at the Jefferies Healthcare Conference on June 5 at 9:00 a.m. ET.

When is GeneDx's presentation at the Goldman Sachs Global Healthcare Conference?

GeneDx will present at the Goldman Sachs Global Healthcare Conference on June 10 at 3:20 p.m. ET.

Where can I watch GeneDx's presentations from the investor conferences?

Live and archived webcasts of GeneDx's presentations will be available on the company's investor relations website.

What focus does GeneDx have in the healthcare industry?

GeneDx focuses on delivering improved health outcomes through genomic insights and provides exome and genome tests for personalized health plans.